RxDoctor Payments Data

Abdul Saied Calvino, MD

Surgical Oncology · Providence, RINPI 1770732497

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $13,726 of the $18,080 with a category attached, or 75.9%. Covidien LP accounts for 78.4% of it on its own, with 7 other manufacturers making up the rest. Reporting peaked in 2020 at $14,167 and has fallen 79.2% since, to $2,954 in 2024.

$18,080in general payments, 2019–2025

Across 33 payments — averaging $547.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Covidien LP$14K
  • Medtronic$2K
  • Stryker$1K
  • Intuitive Surgical$240
  • Sirtex Medical Inc$169
  • Intera Oncology, Inc$131
  • plus $200 from 2 others

What the payments were for

  • Consulting fees$13,72676%
  • Travel & lodging$2,71615%
  • Food & beverage$1,5919%
  • Education$470%

General payments by program year

19
20
21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Covidien LP13$14,167
Medtronic8$2,150
Stryker3$1,023
Intuitive Surgical5$240
Sirtex Medical Inc1$169
Intera Oncology, Inc1$131
Merck1$101
Eisai Inc.1$99

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few surgical oncology providers in Rhode Islandto place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024
$21,875
Medicare patients
32
Services billed
56

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other surgical oncology in Providence

See the full list for Rhode Island

Where these figures come from

Is this you, or does something look wrong? →